The European Medicines Agency (EMA) is working to secure additional doses of the COVID-19 vaccine developed by Pfizer and BioNTech with an aim to deliver 1.8 billion doses to Europe by the end of 2023 ...
The mRNA revolution didn’t end with COVID-19 – it’s only just beginning. With the MHRA’s latest guidance on personalized mRNA cancer vaccines and the world’s first RNA-based CRISPR therapy changing ...
US Government cuts to mRNA vaccine research could set back technological advances and reduce access to therapies, while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results